Research & Development

久久99re热在线播放久久青青草热超碰东京一本道综合网昌兴国际飙逾85.39% 超过39%抵押股份遭沽售


  穿著游泳衣的藍田噗通一聲就跳進了水池子,像一只青蛙一般在水里來回游動了七八個來回,就抱著水池邊上的木頭杠子回氣。   接過童子奉上的涼茶,痛快的牛飲了一碗,就迫不及待的對瑕丘江公道︰“江公,你如何看待雲瑯此人?”久久99re热在线播放   一曲罷了,李延年振衣而起,穿過樂師隊伍,跪拜在阿嬌車馬前高聲道︰“協律都尉李延年恭迎貴人降臨犬台宮。”久久青青草热超碰   去年秋日交易後的羌人,在開春這個時候也開始忙碌起來,牛羊貼膘的活動要從現在一直延續到初雪。   劉徹淡淡的道︰“問你父親要,就說是朕說的。”东京一本道综合网   當這些人戰戰兢兢的坐在椅子上的時候,雲瑯輕聲道︰“就這些人吧?”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo